The share price of The AES Corporation (NYSE:AES) surged by 9.29% between July 7 and July 11, 2025, putting it among the ...

Long-term results from the phase 2 OVARIO trial (NCT03326193) highlight the effectiveness of niraparib plus bevacizumab as maintenance therapy in patients with advanced ovarian cancer.

The Board of Directors of The AES Corporation (NYSE: AES) declared a quarterly common stock dividend of $0.17595 per ...

The Board of Directors of The AES Corporation (NYSE: AES) declared a quarterly common stock dividend of $0.17595 per share ...

A Wall Street maxim states, “Twenty percent of investors who want to make money are in stocks, while the other 80 percent who ...

AES Corp is not a stock that makes headlines for significant price fluctuations, but investors were startled this week when ...

AES Corp. closed 38.87% below its 52-week high of $20.30, which the company reached on October 1st.

AES Corporation’s core value still hinges on major data center power contracts and steady cash flows. Click here to find out ...

AES was pivoting from fossil fuels to renewables, even before a 2018 push by activist investor ValueAct Capital Management.

The minutes for the mid-June meeting showed that most Fed officials said they expect rate cuts will be appropriate later this ...

AES shares are trading higher after Bloomberg reported that the company is exploring options amid takeover interest.

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...